GENERIC NAME OF THE MEDICINAL PRODUCT:
B) Paliperidone Extended-Release Tablets USP 3mg
C) Paliperidone Extended-Release Tablets USP 6mg
D) Paliperidone Extended-Release Tablets USP 9mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated Extended-Release tablet contains:
Paliperidone IP 1.5mg
Excipients q.s.
Colours: Indigo carmine
B) Paliperidone Extended-Release Tablets IP 3mg
Each film coated Extended-Release tablet contains:
Paliperidone IP 3mg
Excipients q.s.
Colours: Indigo carmine
C) Paliperidone Extended-Release Tablets IP 6mg
Each film coated Extended-Release tablet contains:
Paliperidone IP 6mg
Excipients q.s.
Colours: Pigment yellow 3
D) Paliperidone Extended-Release Tablets IP 9mg
Each film coated Extended-Release tablet contains:
Paliperidone IP 9mg
Excipients q.s.
Colours: Quinoline yellow SS
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of a Psychiatrist only.
STORAGE & DOSAGE:
Protect from Light and moisture.
Dosage: As directed by the Physician
Attach dispensing label as per end county.
Paliperidone Extended-Release Tablets 3mg Technical Specification:
| Product Name: | Paliperidone Extended-Release Tablets USP |
| Brand Name: | Generic |
| Strength: | 1.5mg, 3mg, 6mg, 9mg |
| Dosage Form: | Tablets (Film coated Extended-Release) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Antipsychotic |
| Indication: | Paliperidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). |
| Storage: | Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
A) Paliperidone Extended-Release Tablets USP 1.5mg
B) Paliperidone Extended-Release Tablets USP 3mg
C) Paliperidone Extended-Release Tablets USP 6mg
D) Paliperidone Extended-Release Tablets USP 9mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Paliperidone Extended-Release Tablets IP 1.5mg
Each film coated Extended-Release tablet contains:
Paliperidone IP 1.5mg
Excipients q.s.
Colours: Indigo carmine
B) Paliperidone Extended-Release Tablets IP 3mg
Each film coated Extended-Release tablet contains:
Paliperidone IP 3mg
Excipients q.s.
Colours: Indigo carmine
C) Paliperidone Extended-Release Tablets IP 6mg
Each film coated Extended-Release tablet contains:
Paliperidone IP 6mg
Excipients q.s.
Colours: Pigment yellow 3
D) Paliperidone Extended-Release Tablets IP 9mg
Each film coated Extended-Release tablet contains:
Paliperidone IP 9mg
Excipients q.s.
Colours: Quinoline yellow SS
THERAPEUTIC INDICATIONS:
Paliperidone is used to treat the symptoms of psychotic (mental) disorders, including schizophrenia. It may also be used alone or together with other medicines to treat patients with schizoaffective disorder. This medicine should not be used to treat behavioral problems in older adult patients who have dementia.
CAUTION & WARNING:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
Warning: To be sold by retail on the prescription of a Psychiatrist only.
STORAGE & DOSAGE:
Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Protect from Light and moisture.
Dosage: As directed by the Physician
Attach dispensing label as per end county.
Introduction to Paliperidone Extended-Release Tablets 3mg
What is Paliperidone Extended-Release Tablets 3mg?
Paliperidone Extended-Release Tablets 3mg are an oral atypical antipsychotic medication used primarily for the treatment of schizophrenia and schizoaffective disorder in adults. The extended-release technology allows gradual drug release throughout the day, maintaining stable blood levels and reducing fluctuations that may lead to side effects.
Paliperidone is the active metabolite of risperidone and is known for its predictable pharmacokinetics and reduced risk of drug interactions.
Therapeutic Uses
-
Treatment of schizophrenia
-
Management of schizoaffective disorder
-
Treatment of acute manic episodes
-
Maintenance therapy for long-term symptom control
Global Market Demand
The demand for Paliperidone Extended-Release Tablets 3mg export from India is increasing due to:
-
Rising mental health awareness worldwide
-
Preference for once-daily extended-release formulations
-
Cost-effective manufacturing in India
-
Growing access to psychiatric care in emerging economies
Trusted Paliperidone Extended-Release Tablets 3mg Manufacturer Supplier in India
Taj Pharma Ltd India is a well-recognized Manufacturer, Exporter, and Supplier of Paliperidone Extended-Release Tablets 3mg from Vapi, Gujarat, India. The company follows internationally accepted pharmaceutical manufacturing standards, ensuring consistent quality, safety, and efficacy.
Mechanism of Action
Paliperidone is an atypical antipsychotic that works by balancing the activity of dopamine and serotonin, two key neurotransmitters involved in mood, perception, and behavior. This mechanism helps reduce hallucinations, delusions, mood disturbances, and thought disorders.
Possible Side Effects
Some patients may experience:
-
Abnormal involuntary movements
-
Dizziness
-
Sleepiness
-
Tremors
-
Nystagmus (involuntary eye movement)
These effects are usually manageable under proper medical supervision.
In-Depth Information for Importers, Exporters & Buyers
Regulatory Documentation Provided
As a professional Paliperidone Extended-Release Tablets 3mg Supplier, Taj Pharma provides full regulatory support, including:
-
WHO-GMP Certificate
-
Certificate of Pharmaceutical Product (COPP)
-
CTD Dossier (Modules 1–5)
-
Certificate of Analysis (CoA)
-
Stability and dissolution study reports
-
Validation and batch manufacturing records
Custom Packaging & Labeling
Taj Pharma offers customized export packaging solutions:
-
Alu-Alu and PVC/PVDC blister packs
-
HDPE bottle packaging
-
Country-specific artwork and inserts
-
Multilingual labeling
-
Private label and contract manufacturing options
Shelf Life, Storage & Dosage Form
-
Dosage Form: Extended-release oral tablet
-
Strength: 3mg
-
Shelf Life: 24–36 months
-
Storage Conditions: Store below 25°C, protect from light and moisture
Export Certifications
-
WHO-GMP certified manufacturing units
-
ISO-compliant quality management systems
-
EU-GMP supportive documentation (on request)
-
GDP-compliant export and logistics practices
Target Export Markets
Taj Pharma exports Paliperidone Extended-Release Tablets 3mg from India to:
-
Southeast Asia
-
Africa
-
Middle East
-
CIS countries
-
Latin America
Why Taj Pharma is the Most Trusted Paliperidone Manufacturer in India
State-of-the-Art Manufacturing
Taj Pharma’s advanced manufacturing facilities in Vapi, Gujarat are equipped with:
-
Modern extended-release tablet technology
-
Automated production lines
-
Controlled cleanroom environments
-
Rigorous in-process quality checks
Affordable Pricing with Assured Quality
As a leading Paliperidone Extended-Release Tablets 3mg Manufacturer & Supplier, Taj Pharma offers:
-
Competitive export pricing
-
Bulk supply capabilities
-
Strict quality assurance at every stage
Strong Global Supply Chain
Taj Pharma ensures:
-
Timely international deliveries
-
Complete export documentation
-
Reliable long-term supply partnerships
Top 20 Countries Served
India | Vietnam | UAE | Saudi Arabia | Kenya | Tanzania | Nigeria | Philippines | Cambodia | Ghana | Peru | Colombia | Uzbekistan | Kazakhstan | Sri Lanka | Myanmar | Yemen | Oman | South Africa | Chile
Technical Product Specification
| Parameter | Specification |
|---|---|
| Product Name | Paliperidone Extended-Release Tablets 3mg |
| Active Ingredient | Paliperidone |
| Strength | 3mg |
| Dosage Form | Extended-Release Tablet |
| Therapeutic Class | Atypical Antipsychotic |
| Route of Administration | Oral |
| Packaging | Blister / Bottle |
| Shelf Life | 24–36 Months |
| Storage | Below 25°C |
| Certification | WHO-GMP, ISO |
| Manufacturer | Taj Pharma Ltd |
| Country of Origin | India |
PAN India Presence & PCD Pharma Franchise Opportunities
Taj Pharma is widely recognized as:
-
Paliperidone Extended-Release Tablets 3mg PAN India Manufacturer
-
Paliperidone Extended-Release Tablets 3mg Manufacturer Supplier and PCD Pharma Franchise
-
Paliperidone Extended-Release Tablets 3mg Manufacturer from Mumbai
-
Paliperidone Extended-Release Tablets 3mg Manufacturer in Vapi, Gujarat
PCD franchise partners benefit from monopoly rights, marketing support, promotional materials, and consistent supply across India.
Top 20 FAQs
-
What is Paliperidone ER 3mg used for?
Schizophrenia and schizoaffective disorder. -
Is Taj Pharma WHO-GMP certified?
Yes. -
Can Taj Pharma export globally?
Yes. -
Is COPP available?
Yes. -
Is CTD dossier provided?
Yes. -
Is private labeling possible?
Yes. -
Where is Taj Pharma located?
Vapi, Gujarat, India. -
What is the shelf life?
24–36 months. -
Is bulk supply available?
Yes. -
Is it prescription-only?
Yes. -
Are stability studies conducted?
Yes. -
Does Taj Pharma support tenders?
Yes. -
Is Mumbai supply available?
Yes. -
Are African markets supported?
Yes. -
Is pricing competitive?
Yes. -
Is extended-release technology used?
Yes. -
Is PCD franchise available?
Yes. -
Are batches quality tested?
Yes. -
Are export documents complete?
Yes. -
How can buyers contact Taj Pharma?
Directly via official inquiry channels.
If you are searching for a Leading 1 Paliperidone Extended-Release Tablets 3mg Manufacturer & Supplier in India, Taj Pharma is your trusted partner. With WHO-GMP certified facilities, advanced formulation expertise, regulatory support, and global export capability, Taj Pharma delivers excellence at every stage.
📞 Contact Taj Pharma today to source premium-quality Paliperidone Extended-Release Tablets 3mg – Taj Pharma, customized for your market and regulatory requirements.






